90 Developing Patient-Focused Outcomes for Routine Clinical Care in Glioma: A Synthesis of Qualitative Evidence from the COMBaT Study

Clicks: 13
ID: 326664
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #271 of 286 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 286 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction There is a critical need to identify and routinely measure the outcomes that matter most to people living with glioma. Care needs in this population are complex and variable, yet current clinical practice lacks consistent, systematic approaches to assessing them. This may limit timely symptom management, personalised treatment and improvements in quality-of-life. We present findings from the first stage of the COMBaT study, to develop a person-focused core outcome set for routine glioma care. Methods A qualitative synthesis of existing evidence on patient care was undertaken, including: 1) updated systematic review of qualitative studies; 2) secondary analysis of 19 interviews with adults living with glioma. These data inform a draft list of outcomes designed to reflect the care needs of people with glioma. Outcomes will be refined in collaboration with an advisory group, comprising people with lived experience, clinicians, allied health professionals, and NHS digital infrastructure representatives. Results Data extraction and synthesis of 50 full-text studies are underway. Secondary analysis of interview data is complete. Emerging domains for measurement include: Physical symptoms: seizures; fatigue; sensory changes; weakness; headaches; dexterity; pain; speech and language difficulties. Mental affect, behaviour: cognitive changes; emotional expression; personality changes; depression; anxiety. Social wellbeing: quality-of-life including sleep, energy levels and weight changes. These domains will be refined with the advisory group ahead of systematic prioritisation in July 2026. Conclusions The qualitative synthesis will underpin a draft outcome set, to be prioritised using a modified Delphi process. Psychometric properties of existing patient-reported outcome measures will be mapped to the final set and ratified by stakeholders. The outputs will inform development of an implementation strategy to support consistent, person-focused outcome assessment in routine glioma care.
Reference Key
openalex_W7204437153 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Noreen Hopewell-Kelly, Vimeeka Raj Devarajan, Silvia Goss, Helen Bulbeck, R.C. Burke, Anthony Byrne, Andrew Carson-Stevens, Gwawr Evans, Cerys Harris, Cressida Lorimer, James Powell, Sarah Puntoni, Alasdair G Rooney, Kathy Seddon, Colin Watts, Andrew Wright, Stephanie Sivell, Ameeta Retzer
Are you one of these authors? Claim your profile
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag172.031
URL
https://academic.oup.com/neuro-oncology/article-pdf/28/Supplement_1/noag172.031/70805869/noag172.031.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.